Assay systems

The competitive assay approach to novel chemosensors has been pioneered by Anslyn [143]. These competitive systems are particularly interesting because they reduce the synthetic complexity of the receptor. 

Arimori et al. have used compounds 77 and 78 with 1,5- or 2,6-anthraquinone disulfonates (ADS) in a competitive system for the fluorescence detection of o-fruc-tose [146]. 1,5- or 2,6-ADS binds with 77 or 78 and quenches the fluorescence addition of D-fructose causes decomplexation and fluorescence recovery. 

Lakowicz and co-workers have also used competitive interactions between a ruthenium metal-ligand complex, a boronic acid derivative and D-glucose [147]. The metal-ligand complex forms a reversible complex with 2-tolylboronic acid or 2-methoxyphenyl boronic acid. Complexation is accompanied by a several-fold increase in the luminescent intensity of the ruthenium complex. Addition of D-glucose results in decreased luminescent intensity, which appears to be the result of decreased binding between the metal-ligand complex and the boronic acid. Ruthenium metal-lig- 

Lakowicz has also examined the quenching and recovery of a sulfonated poly-(phenylene ethynylene) by a bisboronic acid viologen (81) on addition of saccharides [150]. The system is D-fructose selective and produces up to 70 fold fluorescence enhancement on addition of saccharides. 

Wang has recently shown that alizarin red S and phenyl boronic acid (PBA) could be used in competitive assays for saccharides [151, 152]. The system is D-fructose selective, which is the expected selectivity for a monoboronic acid system [12]. It takes advantage of the known interaction of alizarin red S with boronic acids [153]. Observed stability constants (X pp) for the PBA alizarin red S assay were 160 for D-fructose and 4.6 M for D-glucose in water at pH 7.4 (phosphate buffer). 

Signal transduction pathways, receptors and ion channels aie important taigets of assay systems due to their amenability to modnlation by therapeutically active compounds, then-widespread occunence and the wide-ranging biological effects they produce. 

Transmission of extracellular signals to the interior of the cell is dependent on receptor-mediated assembly of proteins into signaling complexes at the inner side of the plasma membrane. Protein-protein and protein-lipid interactions are essential in these processes, whereby molecular interaction and proximity provide the spatial and temporal conditions for signaling. Tlie hydrophobic phospholipid bilayer is part of the dynamic processes of enrichment and modulation of lipid components. Utilization of fluorescent proteins interacting witli lipid components allows the analysis of molecular proximity in intact cells and sheds light on the membrane dynamics of signaling processes. 

Reseai ch aimed at the identification of novel antiarrythmic agents is targeting Cl channels. Cl channels are involved in cardiac arrythmia, asthma, CF and diarrhea, thus representing targets for therapeutic approaches. 

Cells grown to confluenoe in 35 mm culture dishes or on plates 

Re-suspend in Cl /I free medium (in the absence or presence of test compounds) 

Long QT syndrome 3 SCN5A (cardiac channel) 1505-1507 Deletion of KQP and length of cardiac causing Prolonged opening action potential, persistent current 

So far, we have discussed the development of integrated molecular sensors using boronic adds. The systems contain a receptor and reporter (fluorophore or chromophore) as part of a discrete molecular unit. However, another approach towards boronic acid-based sensors is also possible where the receptor and a reporter unit are separate as in a competitive assay. A competitive assay requires that the receptor and reporter (typically a commerdal dye) associate under the measurement conditions. The receptor-reporter complex is then selectively dissociated by the addition of the appropriate guests. When the 

Anslyn has also prepared more elaborate C3 symmetric tri-podal boronic acid receptors. The binding of heparin and 190, is monitored through displacement of pyrocatechol violet. The observed stability constant (.Kobs) for 190 was 3.8 X 10 M for unfractionated heparin (UFH) in water at pH 7.4 (HEPES buffer). 

With sensor 191 the binding of the tartrate or malate anions can be detected through the competitive displacement of alizarin complexone. The same sensor system was used for the analysis of malate in pinot noir grapes. When 192 was paired with pyrocatechol violet an assay suitable for the detection of gallic acid in Scotch whiskies was developed. An increase in the concentration of gallic acid correlated with the age of the whiskies. A combination of 191 and 192 and two indicators pyrocatechol violet and bromopyrogallol red can be used to detect the concentrations of tartrate and malate in mixtures. Using 

192 and pyrocatechol violet, the reaction kinetics for the formation of tartaric acid by the dihydroxylation of malic acid could be followed.  

The poor oral bioavailability of drugs is generally assumed to be due to physio-chemical problems, which result in poor solubility in the gastrointestinal (GI) tract or difficulty in diffusion through small intestine epithelial membrane. Furthermore, the biochemical process also contributes to oral bioavailability. The in vitro cell culture models of the intestinal epithelial cell barrier have evolved to become widely used experimental devices. 

In the previous chapter, the log P factor was discussed in detail in this chapter, we will examine other methods of testing transport across membranes. 

The permeability assay uses an artificial membrane composed of hexadecane. Appendix 1 lists examples of how permeability values are assessed and correlated with solubility and the overall potential for a drug candidate to prove as a lead compound. 

Into each well, add 15 xL of a 5% solution of hexadecane in hexane. 

Dry for 45 minutes—one hour to ensure complete evaporation of hexane. 

---

Antibodies have been generated which produce immunoassays that discriminate between GH-V and GH-N. These assay systems have shown that the secretion of GH-V becomes elevated at about three weeks of pregnancy and increases to approximately 15 ng/mL near term (8). The physiological role of GH-V is uncertain. Genetic deficiency of GH-V does not adversely affect pregnancy or fetal development (9). GH-V is a potent growth-stimulator but possesses considerably less lactogenic activity than GH-N (10). There are no clinical appHcations (ca 1993) for GH-V. 

Watson, C., Chen, G., Irving, P. E., Way, J., Chen, W.-J., and Kenakin, T. P. (2000). The use of stimulus-biased assay systems to detect agonist-specific receptor active states Implications for the trafficking of receptor stimulus by agonists. Mol. Pharmacol. 58 1230-1238. 

It is important to note that both the quality and quantity of biological response obtained with a given drug depends very much on the assay system used to make the measurement. If the assay does not have the means to detect a given efficacy, then none will be observed this should not be taken to mean that the drug does not have that particular efficacy. A common case in point... 

Moriya M, Ohta T, Watanabe K, et al. 1983. Eurther mutagenicity studies on pesticides in bacterial reversion assay systems. Mutat Res 116 185-216. 

Epimerization of 4 at C-2 provided 5a-carba-a-DL-galactopyranose (6). When the pentaacetate IS was heated in acetic acid containing sulfuric acid, epimerization occurred at C-2 through an intermediary cyclic acetoxonium ion (18), with anchimeric assistance of the vicinal, axial acetoxyl group. After acetylation, 5a-carba-a-DL-galactopyranose pentaacetate (19) was obtained in a yield of 14% it was converted into 6 by hydrolysis. The antimicrobial activity of the racemate 6 was found to be about half that of the natural antibiotic 7 in the same assay system, indicating that the L-antipode is probably inactive. " ... 

This equation illustrates the components of a competitive protein binding assay system. That is, the reaction system contains both radioactive and non-radioactive free ligand (P and P) and both radioactive and non-radioactive protein bound ligand (P Q and PQ). This type of assay assumes that binding protein will have the same affinity for the labeled or non-labeled material that is being measured. Although this assumption is not always completely valid, it usually causes no problems of consequence with most radioassays or radioimmunoassays. 

In evaluating different assay systems it is convenient to use a table of B/Bq vs dose. By comparing these values for different assays a comparison of the sensitivity of the assay can be made. Thus an insulin assay with 50% binding at a concentration of 40 microunits would show much more sensitivity than an assay with a 30% binding occuring at 100 microunits, since the more the dose is lowered, the greater the percent binding becomes. 

Dinovo, E. C. Miyada, D. S. and Nakamura, R. H. Evaluation of direct and indirect compled enzyme assay systems for measurements of creatine kinase activity. 

Identification of proteins that bind to Z-DNA added one further step to the establishment of the presence of Z-DNA in vivo and its possible biological role. Herbert and Rich [22] demonstrated an in vitro assay system where one type of double-stranded RNA adenosine deaminase, called DRAD-binding Z-DNA. There are evidences that topoisomerase II from Drosophila, hiunan and calf thymus recognizes a number of DNA shapes, including Z-DNA [34,35]. Bloomfield and coworkers [36] have found that the condensation of plasmids is enhanced by Z-DNA conformation in d(CG)n repeats. The information related to B-Z transition [31], the effect of ligands on it [28,29] and X-ray crystal structure data [37,38] appear to suggest that the possible biological role of this polymorphic form of DNA will be soon established. 

This assay system developed by Chaires [136] is a new, powerful and effective tool based on the fundamental thermodynamic principle of equilibrium dialysis for the discovery of ligands that bind to nucleic acids with structural and sequence selectivity. Here, identical concentrations of various nucleic acid samples are dialysed in dispodialysers against a common ligand solution. At equilibrium, the contents of the ligand bound to each nucleic acid are determined and this is correlated directly to the ligand s specificity to a particular sequence. 

The concentrations of PUFA-derived conjugated hydroperoxydienes and oxodienes in biological samples can also be determined by a modification of a spec-trophotometric method originally developed by Fishwick and Swoboda (1977). This assay system involves (1) reduction of conjugated hydroperoxydienes and oxodienes to their corresponding hydroxydienes with... 

An individual automated device within a fully automated assay system that usually performs a complete single assay step or procedure. A fully enclosed MODULE may allow for the control of temperature, humidity, and the gaseous environment. 

The results presented here demonstrate that these approaches can be applied to Potamogeton sp. and Hydrilla verticillata. In both assay systems, typical responses to known plant growth regulators were observed in most cases. The unique response of P.nodosus to ABA however, clearly shows the importance of not relying solely on "classical" bioassays. 

Carbonic anhydrase (CA) exists in three known soluble forms in humans. All three isozymes (CA I, CA II, and CA III) are monomeric, zinc metalloenzymes with a molecular weight of approximately 29,000. The enzymes catalyze the reaction for the reversible hydration of C02. The CA I deficiency is known to cause renal tubular acidosis and nerve deafness. Deficiency of CA II produces osteopetrosis, renal tubular acidosis, and cerebral calcification. More than 40 CA II-defi-cient patients with a wide variety of ethnic origins have been reported. Both syndromes are autosomal recessive disorders. Enzymatic confirmation can be made by quantitating the CA I and CA II levels in red blood cells. Normally, CA I and CAII each contribute about 50% of the total activity, and the CAI activity is completely abolished by the addition of sodium iodide in the assay system (S22). The cDNA and genomic DNA for human CA I and II have been isolated and sequenced (B34, M33, V9). Structural gene mutations, such as missense mutation, nonsense... 

Several pathological self-polymerizing systems have been biophysi-cally characterized sufficiently to permit identification of protein or peptide species that could serve as molecular targets in a structure-activity relationship. These include transthyretin (TTR) [73-76], serum amyloid A protein (SAA) [77], microtubule-associated protein tau [78-80], amylin or islet amyloid polypeptide (IAPP) [81,82], IgG light chain amyloidosis (AL) [83-85], polyglutamine diseases [9,86], a-synuclein [47,48] and the Alzheimer s (3 peptide [87-96]. A variety of A(3 peptide assay systems have been established at Parke-Davis to search for inhibitors of fibril formation that could be therapeutically useful [97]. 

The processes of both seed formation and fibril extension are dependent on temperature and on peptide concentration, with 37°C being required for establishing equilibrium within 24 h with 30 pM Pi 4o- A full description of the assay system may be found elsewhere [97,117], A 4 h reaction time is typically within the linear portion of the time course. This nucleus-dependent assay detects mainly inhibitors that are substoichiometric with the monomeric peptide, which is present at high concentration. It is relatively insensitive to inhibitors that target the monomeric peptide. Whether the inhibitors interact with the growing end of a seed or with a low abundance conformational form of the p peptide that is competent to add to the seed is difficult to determine at this time. Similar dose-response curves are obtained for Congo Red as an inhibitor with either thioflavin T (ThT) fluorescence or filtration of radioiodinated peptide readouts (Fig. 4) Caveats in the interpretation of both the ThT and radiometric filtration assays for the evaluation of putative inhibitors are discussed elsewhere [97]. 

---